KCNE5
Basic information
Region (hg38): X:109623700-109625172
Previous symbols: [ "KCNE1L" ]
Links
Phenotypes
GenCC
Source:
- Brugada syndrome (Limited), mode of inheritance: Unknown
- Brugada syndrome (Disputed Evidence), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNE5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 26 | ||||
missense | 45 | 47 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 51 | 30 | 0 |
Variants in KCNE5
This is a list of pathogenic ClinVar variants found in the KCNE5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-109624334-G-A | Likely benign (Feb 28, 2019) | |||
X-109624598-C-T | not specified | Likely benign (Mar 03, 2022) | ||
X-109624611-T-C | not specified | Uncertain significance (Mar 29, 2022) | ||
X-109624618-G-C | not specified | Uncertain significance (Jul 15, 2023) | ||
X-109624620-G-T | not specified | Uncertain significance (Aug 28, 2023) | ||
X-109624624-G-A | Brugada syndrome | Uncertain significance (Apr 28, 2021) | ||
X-109624625-C-G | Brugada syndrome | Likely benign (Jul 03, 2021) | ||
X-109624634-G-C | Brugada syndrome | Likely benign (Jan 08, 2023) | ||
X-109624647-C-T | Brugada syndrome | Uncertain significance (Sep 22, 2022) | ||
X-109624650-C-A | Brugada syndrome | Uncertain significance (Aug 28, 2021) | ||
X-109624663-G-A | Brugada syndrome • KCNE5-related disorder | Uncertain significance (Sep 14, 2022) | ||
X-109624670-C-T | Brugada syndrome | Likely benign (Mar 01, 2022) | ||
X-109624672-C-T | Brugada syndrome | Uncertain significance (Feb 02, 2022) | ||
X-109624675-C-A | not specified | Uncertain significance (Jan 18, 2023) | ||
X-109624675-C-T | Brugada syndrome • not specified | Conflicting classifications of pathogenicity (Jan 17, 2024) | ||
X-109624682-G-A | Brugada syndrome • not specified | Likely benign (Sep 22, 2023) | ||
X-109624683-GC-TT | Brugada syndrome | Uncertain significance (Dec 01, 2021) | ||
X-109624685-G-T | Brugada syndrome | Uncertain significance (Mar 28, 2021) | ||
X-109624687-C-T | Brugada syndrome • not specified | Conflicting classifications of pathogenicity (Jan 22, 2024) | ||
X-109624688-G-A | Brugada syndrome • not specified | Benign/Likely benign (Jan 17, 2024) | ||
X-109624691-G-A | not specified | Likely benign (Nov 20, 2022) | ||
X-109624691-G-C | not specified | Likely benign (May 11, 2023) | ||
X-109624692-G-T | Brugada syndrome | Uncertain significance (Jan 31, 2021) | ||
X-109624694-C-G | Brugada syndrome • not specified | Likely benign (Jul 05, 2023) | ||
X-109624696-G-A | Brugada syndrome • not specified | Likely benign (Jun 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KCNE5 | protein_coding | protein_coding | ENST00000372101 | 1 | 1465 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.119 | 0.622 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.407 | 60 | 69.5 | 0.863 | 0.00000639 | 876 |
Missense in Polyphen | 10 | 17.284 | 0.57858 | 246 | ||
Synonymous | 1.32 | 26 | 36.1 | 0.721 | 0.00000366 | 318 |
Loss of Function | 0.396 | 1 | 1.53 | 0.654 | 1.33e-7 | 20 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Potassium channel ancillary subunit that is essential for generation of some native K(+) currents by virtue of formation of heteromeric ion channel complex with voltage-gated potassium (Kv) channel pore-forming alpha subunits. Functions as an inhibitory beta-subunit of the repolarizing cardiac potassium ion channel KCNQ1. {ECO:0000269|PubMed:12324418}.;
- Pathway
- Antiarrhythmic Pathway, Pharmacodynamics;Phase 2 - plateau phase;Phase 3 - rapid repolarisation;Cardiac conduction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.106
Haploinsufficiency Scores
- pHI
- 0.237
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Kcne1l
- Phenotype
Gene ontology
- Biological process
- regulation of heart contraction;cardiac muscle contraction;regulation of membrane repolarization;regulation of ventricular cardiac muscle cell membrane repolarization;regulation of atrial cardiac muscle cell membrane repolarization;ventricular cardiac muscle cell action potential;membrane repolarization during action potential;atrial cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;potassium ion export across plasma membrane;membrane repolarization during ventricular cardiac muscle cell action potential;regulation of potassium ion transmembrane transport;negative regulation of potassium ion transmembrane transport;positive regulation of potassium ion transmembrane transport;negative regulation of delayed rectifier potassium channel activity;negative regulation of potassium ion export across plasma membrane;regulation of cation channel activity
- Cellular component
- plasma membrane;voltage-gated potassium channel complex
- Molecular function
- voltage-gated potassium channel activity;delayed rectifier potassium channel activity;protein binding;potassium channel regulator activity;ion channel binding;voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization;voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization